Sio Capital Management, LLC Salarius Pharmaceuticals, Inc. Transaction History

Sio Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.34 - $0.54 $460,458 - $731,317	-1,354,291 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.02 - $1.52 $1.8 Million - $2.68 Million	-1,764,405 Reduced 56.58%	1,354,291 $1.44 Million
Q1 2021 May 14, 2021	BUY	$1.0 - $3.0 $1.46 Million - $4.38 Million	1,461,454 Added 88.19%	3,118,696 $4.62 Million
Q4 2020 Feb 16, 2021	BUY	$0.65 - $1.34 $1.08 Million - $2.22 Million	1,657,242 New	1,657,242 $1.51 Million

Ticker SLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,244,650
Market Cap $3.48M
Description
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a ...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.